GOLM1 Antibody (monoclonal) (M06)
Mouse monoclonal antibody raised against a partial recombinant GOLM1.
- SPECIFICATION
- CITATIONS: 1
- PROTOCOLS
- BACKGROUND
Application ![]()
| WB, IHC, IF, E |
---|---|
Primary Accession | Q8NBJ4 |
Other Accession | NM_016548 |
Reactivity | Human |
Host | mouse |
Clonality | Monoclonal |
Isotype | IgG1 Kappa |
Clone Names | 5B10 |
Calculated MW | 45333 Da |
Gene ID | 51280 |
---|---|
Other Names | Golgi membrane protein 1, Golgi membrane protein GP73, Golgi phosphoprotein 2, GOLM1, C9orf155, GOLPH2 |
Target/Specificity | GOLM1 (NP_057632, 302 a.a. ~ 401 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | GOLM1 Antibody (monoclonal) (M06) is for research use only and not for use in diagnostic or therapeutic procedures. |

Provided below are standard protocols that you may find useful for product applications.
Background
The Golgi complex plays a key role in the sorting and modification of proteins exported from the endoplasmic reticulum. The protein encoded by this gene is a type II Golgi transmembrane protein. It processes proteins synthesized in the rough endoplasmic reticulum and assists in the transport of protein cargo through the Golgi apparatus. The expression of this gene has been observed to be upregulated in response to viral infection. Alternatively spliced transcript variants encoding the same protein have been described for this gene.
References
1.The HOPE fixation technique - a promising alternative to common prostate cancer biobanking approaches.Braun M, Menon R, Nikolov P, Kirsten R, Petersen K, Schilling D, Schott C, Gundisch S, Fend F, Becker KF, Perner S.BMC Cancer. 2011 Dec 7;11:511.2.ERG rearrangement in small cell prostatic and lung cancer.Scheble VJ, Braun M, Wilbertz T, Stiedl AC, Petersen K, Schilling D, Reischl M, Seitz G, Fend F, Kristiansen G, Perner S.Histopathology. 2010 Jun;56(7):937-43.3.GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics.Kristiansen G, Fritzsche FR, Wassermann K, Jager C, Tolls A, Lein M, Stephan C, Jung K, Pilarsky C, Dietel M, Moch H.Br J Cancer. 2008 Sep 16;99(6):939-48.4.GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.Wei S, Dunn TA, Isaacs WB, De Marzo AM, Luo J.Prostate. 2008 Sep 15;68(13):1387-95.

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.